Almac's £2m link with Scottish firm to aid cancer fight
Almac Discovery, part of the Craigavon-based pharmaceutical group, has received a £2m grant for a cancer research partnership.
It will partner with Scottish company Elasmogen under a new oncology-based project.
The two companies were awarded the grant through Innovate UK's innovation in health and life sciences funding programme.
Stephen Barr, president and managing director at Almac Discovery, said: "It is heartening to be able to continue and also broaden our successful collaboration with Elasmogen so that we may remain at the forefront of oncology discovery and ultimately benefit patients."